FI55503C - FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT - Google Patents

FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT

Info

Publication number
FI55503C
FI55503C FI2825/72A FI282572A FI55503C FI 55503 C FI55503 C FI 55503C FI 2825/72 A FI2825/72 A FI 2825/72A FI 282572 A FI282572 A FI 282572A FI 55503 C FI55503 C FI 55503C
Authority
FI
Finland
Prior art keywords
pyrimidinonderivat
framework
preparation
therapeutic animal
animal thermal
Prior art date
Application number
FI2825/72A
Other languages
Finnish (fi)
Other versions
FI55503B (en
Inventor
Christopher Andrew Lipinski
John Gerritt Stam
Gerald George De Angelis
Hans-Jurgen Ernst Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to FI781204A priority Critical patent/FI55504C/en
Application granted granted Critical
Publication of FI55503B publication Critical patent/FI55503B/en
Publication of FI55503C publication Critical patent/FI55503C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI2825/72A 1971-10-29 1972-10-12 FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT FI55503C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI781204A FI55504C (en) 1971-10-29 1978-04-19 PROCEDURE FOR THE PREPARATION OF THERAPEUTIC HYDROXY-PYRIMIDINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (2)

Publication Number Publication Date
FI55503B FI55503B (en) 1979-04-30
FI55503C true FI55503C (en) 1979-08-10

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2825/72A FI55503C (en) 1971-10-29 1972-10-12 FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH549579A (en)
DE (3) DE2264657C2 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377308A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL84634B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
CA2620065C (en) 2005-08-22 2011-03-29 Melior Discovery, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
BR112019021140A2 (en) 2017-04-10 2020-05-19 Univ Louisiana State composition, method to reduce blood glucose levels, weight gain or fat deposit levels, or treatment, adipocyte beige induction method or preventing pancreatic beta cell degeneration, and lyn kinase activator and agonist of trpm8 for use in reducing blood glucose levels, weight gain or fat deposit levels, or treatment.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
PL84634B1 (en) 1976-04-30
SU498908A3 (en) 1976-01-05
NO136574B (en) 1977-06-20
YU36295B (en) 1982-06-18
IE37043B1 (en) 1977-04-27
DE2264374C3 (en) 1981-07-23
EG11013A (en) 1976-11-30
DK131465B (en) 1975-07-21
NO136574C (en) 1977-09-28
IL48790A0 (en) 1976-03-31
DK131465C (en) 1975-12-08
PH10129A (en) 1976-09-02
JPS5337870B2 (en) 1978-10-12
IL40458A (en) 1976-05-31
IL40458A0 (en) 1972-11-28
FR2157865B1 (en) 1975-10-31
CH549579A (en) 1974-05-31
AR198798A1 (en) 1974-07-24
NL166470B (en) 1981-03-16
DE2264657C2 (en) 1982-09-16
JPS53116386A (en) 1978-10-11
FR2157865A1 (en) 1973-06-08
IE37043L (en) 1973-04-29
AU467600B2 (en) 1975-12-04
YU35125B (en) 1980-09-25
DE2264374A1 (en) 1973-05-24
LU66304A1 (en) 1973-05-03
PH11594A (en) 1978-03-31
DE2248741A1 (en) 1973-05-03
AR196263A1 (en) 1973-12-10
SE397090B (en) 1977-10-17
CH555832A (en) 1974-11-15
DE2264657A1 (en) 1974-06-20
DE2248741B2 (en) 1974-11-14
SE7505279L (en) 1975-05-06
JPS5422995B2 (en) 1979-08-10
NL7213959A (en) 1973-05-02
CA980778A (en) 1975-12-30
DE2248741C3 (en) 1975-06-26
FI55503B (en) 1979-04-30
ES436624A1 (en) 1977-02-01
IL48790A (en) 1976-05-31
AT321308B (en) 1975-03-25
JPS4852780A (en) 1973-07-24
AT320656B (en) 1975-02-25
SE393376B (en) 1977-05-09
GB1377720A (en) 1974-12-18
ZA727362B (en) 1973-11-28
GB1377308A (en) 1974-12-11
BE790125A (en) 1973-04-16
SU505362A3 (en) 1976-02-28
ES407730A1 (en) 1976-01-16
PL89852B1 (en) 1976-12-31
YU255172A (en) 1980-03-15
NL166470C (en) 1981-08-17
AU4722872A (en) 1974-04-04
DE2264374B2 (en) 1980-08-07
YU99179A (en) 1981-08-31

Similar Documents

Publication Publication Date Title
SE392269B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN INDANYLOXITETRAZOLES
SE398877B (en) PROCEDURE FOR THE PREPARATION OF 14-HYDROXY-MORPHINAND DERIVATIVES
SE400292B (en) PROCEDURE FOR THE PREPARATION OF BENZHYDRYL-3-CARBAMOYLOXIMETHYL-7-THIENYLACETAMIDO-7-METHOXIDE CEFALOSPORANATE
SE399701B (en) PROCEDURE FOR THE PREPARATION OF HYDROXYALKYLDIAMINE
FI55503B (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ANIMAL THERMAL PYRIMIDINONDERIVAT
SE394436B (en) PROCEDURE FOR THE PREPARATION OF 7-HALOGEN-LINCOMYCINES
FI54602C (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPY OF 6-AMIDINOPENICILLANSYRADERIVAT
SE417200B (en) PROCEDURE FOR THE PREPARATION OF 2-NITRO-5-IMIDAZOLALDEHYD HYDRIATIVES
SE405478B (en) PROCEDURE FOR THE PREPARATION OF ALFA-SULFOACYLCEPHALOSPORINES
SE412756B (en) ALTERNATIVE PROCEDURE FOR THE PREPARATION OF 2- (AMINOPHENYLIMINO) -3-AZA-1-TIA-CYCLOALKANES
SE385011B (en) PROCEDURE FOR THE PREPARATION OF ALFA-LINCOSAMINIDES
SE384686B (en) PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES
SE408418B (en) PROCEDURE FOR THE PREPARATION OF 5-FLUOR-PYRIMIDINES
SE408177B (en) PROCEDURE FOR THE PREPARATION OF 4-HYDROXIMETHYL-1-PHTHALAZONE DERIVATIVES
SE387936B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED METHOXYAMINES
SE380520B (en) PROCEDURE FOR THE PREPARATION OF 1-CINNAMYLIDENAMINO-3-BENZYLIDENAMINOGUANIDINE
SE380795B (en) PROCEDURE FOR THE PREPARATION OF THIOCARBAMIDS
SE386897B (en) PROCEDURE FOR THE PREPARATION OF N-ACYL- (PIPERAZINOETHYL) -PYRAZOLES
SE392902B (en) PROCEDURE FOR THE PREPARATION OF PHENYLIMIDAZOLIDINONES
SE382046B (en) PROCEDURE FOR THE PREPARATION OF 1-ARYLOXY-2-PROPANOL
SE405730B (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES
SE397350B (en) PROCEDURE FOR THE PREPARATION OF TIENO-DIAZEPINE DERIVATIVES
SE387948B (en) PROCEDURE FOR THE PREPARATION OF TIOFEN
SE407061B (en) PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINES
SE392724B (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEFALOSPORANIC ACID